Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers.
Arnaldi D, De Carli F, Famà F, Brugnolo A, Girtler N, Picco A, Pardini M, Accardo J, Proietti L, Massa F, Bauckneht M, Morbelli S, Sambuceti G, Nobili F.
Arnaldi D, et al. Among authors: sambuceti g.
Mov Disord. 2017 Dec;32(12):1738-1747. doi: 10.1002/mds.27190. Epub 2017 Nov 9.
Mov Disord. 2017.
PMID: 29119593